Recital 35, Regulation (EU) 2026/1392

In forcesince 20 May 2026

Genetically modified FRM should only be marketed if it is safe for human health and the environment and has been authorised for cultivation pursuant to Directive 2001/18/EC [Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC (OJ L 106, 17.4.2001, p. 1, ELI: http://data.europa.eu/eli/dir/2001/18/oj).] or Regulation (EC) No 1829/2003 [Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed (OJ L 268, 18.10.2003, p. 1, ELI: http://data.europa.eu/eli/reg/2003/1829/oj).] of the European Parliament and of the Council and if that FRM belongs to the ‘tested’ category. It should be possible to market FRM obtained by certain new genomic techniques only if it complies with the requirements of Regulation (EU) 2026/1388 of the European Parliament and of the Council [Regulation (EU) 2026/1388 of the European Parliament and of the Council of 17 June 2026 on plants obtained by certain new genomic techniques and their products, and amending Regulation (EU) 2017/625 (OJ L, 2026/1388, 26.6.2026, ELI: http://data.europa.eu/eli/reg/2026/1388/oj).] and if that FRM belongs to the ‘tested’ category.